Australia Patent: Laboratorio Avi-Mex de C.V., Icahn School of Medicine at Mount Sinai File Application for 'Recombinant vaccine against covid-19 based on a paramyxovirus viral vector'

Press/Media

Period	16 Dec 2022

Media coverage

Title	Australia Patent: Laboratorio Avi-Mex de C.V., Icahn School of Medicine at Mount Sinai File Application for 'Recombinant vaccine against covid-19 based on a paramyxovirus viral vector'
Media name/outlet	Australian Government News (Ht Media)
Country/Territory	Australia
Date	16/12/22
URL	ct.moreover.com/?a=49518072879&p=1gw&v=1&x=NcgEMiFb8pyd2rpg32xLMA
Persons	Florian Krammer, Peter Palese, Weina Sun